U.S. RESEARCH ROUNDUP-Allscripts Healthcare Solutions, Iovance Biotherapeutics, Zebra Technologies

Heartland Express

05/11/2019 07:12

Nov 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Allscripts Healthcare Solutions, Iovance
Biotherapeutics and Zebra Technologies, on Tuesday. 
    
  HIGHLIGHTS
     * Allscripts Healthcare Solutions  MDRX.O : Jefferies ups price target to $14.50 from $13
     * Iovance Biotherapeutics  IOVA.O : Baird raises target price to $60 from $56
     * Zebra Technologies Corp  ZBRA.O : JP Morgan cuts to neutral from overweight
 
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
   
     * Acorda Therapeutics Inc  ACOR.O : Jefferies cuts price target to $2 from $3
     * Adobe Inc  ADBE.O : Jefferies raises price target to $350 from $340
     * Adobe Inc  ADBE.O : JP Morgan raises target price to $322 from $318
     * Adobe Systems Inc  ADBE.O : JP Morgan raises price target to $322 from $318
     * Agnc Investment Corp  AGNC.O : JP Morgan raises Dec 2020 price target to $17 from $16.50
     * Allscripts Healthcare Solutions  MDRX.O : Evercore ISI raises target price to $11 
     * Allscripts Healthcare Solutions  MDRX.O : Jefferies ups price target to $14.50 from $13
     * Analog Devices Inc  ADI.O : RBC raises target price to $136 from $130
     * Anworth Mortgage Asset Corp  ANH.N : Credit Suisse cuts target price to $3.25 from $3.50
     * Ardagh Group SA  ARD.N : RBC raises target price to $20 from $18
     * Basic Energy Services Inc  BAS.N : Evercore ISI cuts target price to $1 from $3
     * Booking Holdings Inc  BKNG.O : Credit Suisse raises price target to $2340 from $2250
     * Ceridian Hcm Holding Inc  CDAY.N : JP Morgan establishes Dec 2020 price target of $47 
     * Cisco  CSCO.O : Credit Suisse cuts target price to $49 from $50
     * Constellation Pharmaceuticals  CNST.O : JP Morgan raises Dec 2020 pt to $20 from $14
     * Deciphera Pharmaceuticals Inc  DCPH.O : Jefferies raises price target to $53 from $47
     * Deciphera Pharmaceuticals Inc  DCPH.O : JP Morgan raises price target to $48 from $40
     * Dominion Energy Inc  D.N : JP Morgan cuts target price to $85 from $86
     * Everbridge Inc  EVBG.O : Canaccord Genuity cuts price target to $90 from $105
     * Everbridge Inc  EVBG.O : Credit Suisse cuts target price to $90 from $100
     * Everbridge Inc  EVBG.O : JP Morgan cuts target price to $80 from $93
     * Everquote Inc  EVER.O : Canaccord Genuity raises target price to $34 from $25
     * Expedia Group Inc  EXPE.O : Credit Suisse raises price target to $164 from $152
     * Fabrinet  FN.N : Piper Jaffray raises target price to $68 from $64
     * First Horizon National Corp  FHN.N : RBC raises target price to $18 from $17
     * First Republic Bank  FRC.N : Evercore ISI raises target price to $115 from $105
     * First Republic Bank  FRC.N : RBC raises target price to $110 from $105
     * Guidewire Software Inc  GWRE.N : D.A. Davidson raises price target to $133 from $125
     * Hartford Financial Services Group  HIG.N : JP Morgan raises target price to $63 from $57
     * Heartland Express Inc  HTLD.O : JP Morgan raises price target to $22 from $20
     * Iovance Biotherapeutics  IOVA.O : Baird raises target price to $60 from $56
     * Karyopharm Therapeutics  KPTI.O : Canaccord Genuity raises target price to $18 from $15
     * Karyopharm Therapeutics  KPTI.O : RBC raises target price to $23 from $21
     * Luminex Corp  LMNX.O : JP Morgan cuts price target to $18 from $21
     * Maxar Technologies Inc  MAXR.N : CIBC raises target price to $6.25 from $5.5
     * Maxar Technologies Inc  MAXR.N : JP Morgan raises price target to $15 from $12
     * Mirati Therapeutics Inc  MRTX.O : JP Morgan raises price target to $88 from $85
     * Myokardia Inc  MYOK.O : JP Morgan raises price target to $92 from $84
     * Myriad Genetics Inc  MYGN.O : Cowen and Company cuts price target to $21 from $30
     * Myriad Genetics Inc  MYGN.O : JP Morgan cuts price target to $20 from $27
     * Neurocrine Biosciences  NBIX.O : Canaccord Genuity raises price target to $122 from $120
     * Neurocrine Biosciences  NBIX.O : Cowen and Company raises price target to $110 from $105
     * Neurocrine Biosciences  NBIX.O : JP Morgan raises target price to $116 from $114
     * Neurocrine Biosciences  NBIX.O : RBC raises target price to $125 from $121
     * Olin Corp  OLN.N : RBC cuts target price to $18 from $19
     * Owens-Illinois Inc  OI.N : RBC cuts target price to $10 from $15
     * Prudential Financial Inc  PRU.N : Evercore ISI cuts target price to $85 from $92
     * Prudential Financial Inc  PRU.N : JP Morgan cuts price target to $110 from $115
     * Ryanair Holdings Plc  RYAAY.O : Evercore ISI raises target price to $85 from $70
     * Sempra Energy  SRE.N : JP Morgan raises target price to $149 from $148
     * Shake Shack Inc  SHAK.N : Cowen and Company cuts price target to $70 from $71
     * Shake Shack Inc  SHAK.N : JP Morgan cuts target price to $63 from $69
     * Shake Shack Inc  SHAK.N : Stifel cuts price target to $60 from $80
     * Shake Shack Inc  SHAK.N : Stifel cuts target price to $60 from $80
     * Solaris Oilfield Infrastructure  SOI.N : Evercore ISI cuts target price to $17 from $19
     * Sysco Corp  SYY.N : Jefferies raises price target to $74 from $67
     * Tactile Systems Technology  TCMD.O : Canaccord Genuity ups price target to $77 from $75
     * Taiwan Semiconductor Manufacturing Co  TSM.N : Bernstein raises pt to $56 from $47
     * Tandem Diabetes Care Inc  TNDM.O : Baird cuts target price to $71 from $81
     * Tenaris  TS.N : Goldman Sachs cuts target price to $20.6 from $28.5
     * Uber Technologies Inc  UBER.N : RBC raises target price to $64 from $62
     * under Armour Inc  UAA.N : Cowen and Company cuts price target to $17 from $21
     * under Armour Inc  UAA.N : Evercore ISI cuts target price to $25 from $33
     * US Xpress Enterprises Inc  USX.N : JP Morgan cuts price target to $6 from $6.50
     * Vir Biotechnology  VIR.O : JP Morgan initiates with overweight rating; $25 DEC-2020 PT
     * Zebra Technologies Corp  ZBRA.O : JP Morgan cuts to neutral from overweight
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))